About PMPRB
PMPRB offers products and services including Price Regulation Services and Pharmaceutical Reporting.
- SectorsHealthcare
- Social X
- Legal Name Patented Medicine Prices Review Board
Products & Services of PMPRB
PMPRB offers a comprehensive portfolio of products and services, including Price Regulation Services and Pharmaceutical Reporting.
Regulation of patented medicine prices is conducted to ensure they are not excessive, involving investigations and hearings
Reporting on trends in pharmaceuticals is performed through various studies and analyses of sales, costs, and pricing
Web traffic of PMPRB
Websites that share an audience with PMPRB (pmprb-cepmb.gc.ca).
Websites whose visitors overlap most with PMPRB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pdci.ca | 81% | – | – | View details |
Similar companies to PMPRB
10 companies that operate in the same segment as PMPRB (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PMPRB
The Patented Medicine Prices Review Board is recognized for ensuring that prices of patented medicines in Canada are not excessive, with responsibilities including the protection and informing of Canadians on pharmaceutical matters. Reports such as the Biologics in Canada series and Meds Entry Watch are produced to analyze trends in sales, costs, and pricing of medicines. Consultations on guidelines are conducted under the Patent Act, while scientific reviews and hearings are utilized to manage price investigations. This framework supports ongoing proceedings and regulatory oversight in the healthcare sector, contributing to balanced pharmaceutical practices as of 2020 updates.
PMPRB offers Price Regulation Services and Pharmaceutical Reporting.
PMPRB operates through Patented Medicine Prices Review Board.